Selected research
Market Structure
Global Bio Simulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Bio Simulation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Bio Simulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Bio Simulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bio Simulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Bio Simulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bio Simulation include Medtronic, Simulations Plus Inc., Schrodinger Inc., Rhenovia Pharma, PPD Inc., Physiomics Plc, Intelligen Inc., Genedata AG and Entelos Holding Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Bio Simulation market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bio Simulation and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bio Simulation revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Bio Simulation market size, projected growth trends, production technologies, key applications, and end-use industries.
Bio Simulation Segment by Company
Medtronic
Simulations Plus Inc.
Schrodinger Inc.
Rhenovia Pharma
PPD Inc.
Physiomics Plc
Intelligen Inc.
Genedata AG
Entelos Holding Corporation
Dassault Systemes SE
Chemical Computing Group
Certara LP
ANSYS Inc.
Altair Engineering Inc.
Advanced Chemistry Development
Bio Simulation Segment by Type
Software
Services
Bio Simulation Segment by Application
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Other End Users
Bio Simulation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio Simulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bio Simulation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio Simulation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Bio Simulation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bio Simulation industry.
Chapter 3: Detailed analysis of Bio Simulation companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bio Simulationrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Software
- Services
Applications
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Other End Users
Companies covered
- Medtronic
- Simulations Plus Inc.
- Schrodinger Inc.
- Rhenovia Pharma
- PPD Inc.
- Physiomics Plc
- Intelligen Inc.
- Genedata AG
- Entelos Holding Corporation
- Dassault Systemes SE
- Chemical Computing Group
- Certara LP
- ANSYS Inc.
- Altair Engineering Inc.
- Advanced Chemistry Development
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Bio Simulation Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Software
- 1.2.3 Services
- 1.3 Market Analysis by Application
- 1.3.1 Global Bio Simulation Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical and Biotechnology Companies
- 1.3.3 Contract Research Organizations
- 1.3.4 Other End Users
- 1.4 Global Market Growth Prospects
- 1.5 Global Bio Simulation Growth Trends by Region
- 1.5.1 Global Bio Simulation Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Bio Simulation Market Size by Region (2021-2026)
- 1.5.3 Bio Simulation Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Bio Simulation Market Dynamics
- 2.1 Bio Simulation Industry Trends
- 2.2 Bio Simulation Industry Drivers
- 2.3 Bio Simulation Industry Opportunities and Challenges
- 2.4 Bio Simulation Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Bio Simulation Revenue by Company (2021-2026)
- 3.2 Global Bio Simulation Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Bio Simulation Key Company Head office and Area Served
- 3.4 Global Bio Simulation Company, Product Type & Application
- 3.5 Global Bio Simulation Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Bio Simulation Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Bio Simulation Players Market Share by Revenue in 2025
- 3.6.3 2025 Bio Simulation Tier 1, Tier 2, and Tier 3
4 Bio Simulation Market by Type
- 4.1 Global Bio Simulation Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Bio Simulation Market Size by Type (2021-2032)
- 4.3 Global Bio Simulation Market Size Share by Type (2021-2032)
5 Bio Simulation Market by Application
- 5.1 Global Bio Simulation Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Bio Simulation Market Size by Application (2021-2032)
- 5.3 Global Bio Simulation Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Medtronic
- 6.1.1 Medtronic Company Information
- 6.1.2 Medtronic Business Overview
- 6.1.3 Medtronic Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Medtronic Bio Simulation Product Portfolio
- 6.1.5 Medtronic Recent Developments
- 6.2 Simulations Plus Inc.
- 6.2.1 Simulations Plus Inc. Company Information
- 6.2.2 Simulations Plus Inc. Business Overview
- 6.2.3 Simulations Plus Inc. Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Simulations Plus Inc. Bio Simulation Product Portfolio
- 6.2.5 Simulations Plus Inc. Recent Developments
- 6.3 Schrodinger Inc.
- 6.3.1 Schrodinger Inc. Company Information
- 6.3.2 Schrodinger Inc. Business Overview
- 6.3.3 Schrodinger Inc. Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Schrodinger Inc. Bio Simulation Product Portfolio
- 6.3.5 Schrodinger Inc. Recent Developments
- 6.4 Rhenovia Pharma
- 6.4.1 Rhenovia Pharma Company Information
- 6.4.2 Rhenovia Pharma Business Overview
- 6.4.3 Rhenovia Pharma Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Rhenovia Pharma Bio Simulation Product Portfolio
- 6.4.5 Rhenovia Pharma Recent Developments
- 6.5 PPD Inc.
- 6.5.1 PPD Inc. Company Information
- 6.5.2 PPD Inc. Business Overview
- 6.5.3 PPD Inc. Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 PPD Inc. Bio Simulation Product Portfolio
- 6.5.5 PPD Inc. Recent Developments
- 6.6 Physiomics Plc
- 6.6.1 Physiomics Plc Company Information
- 6.6.2 Physiomics Plc Business Overview
- 6.6.3 Physiomics Plc Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Physiomics Plc Bio Simulation Product Portfolio
- 6.6.5 Physiomics Plc Recent Developments
- 6.7 Intelligen Inc.
- 6.7.1 Intelligen Inc. Company Information
- 6.7.2 Intelligen Inc. Business Overview
- 6.7.3 Intelligen Inc. Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Intelligen Inc. Bio Simulation Product Portfolio
- 6.7.5 Intelligen Inc. Recent Developments
- 6.8 Genedata AG
- 6.8.1 Genedata AG Company Information
- 6.8.2 Genedata AG Business Overview
- 6.8.3 Genedata AG Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Genedata AG Bio Simulation Product Portfolio
- 6.8.5 Genedata AG Recent Developments
- 6.9 Entelos Holding Corporation
- 6.9.1 Entelos Holding Corporation Company Information
- 6.9.2 Entelos Holding Corporation Business Overview
- 6.9.3 Entelos Holding Corporation Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Entelos Holding Corporation Bio Simulation Product Portfolio
- 6.9.5 Entelos Holding Corporation Recent Developments
- 6.10 Dassault Systemes SE
- 6.10.1 Dassault Systemes SE Company Information
- 6.10.2 Dassault Systemes SE Business Overview
- 6.10.3 Dassault Systemes SE Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Dassault Systemes SE Bio Simulation Product Portfolio
- 6.10.5 Dassault Systemes SE Recent Developments
- 6.11 Chemical Computing Group
- 6.11.1 Chemical Computing Group Company Information
- 6.11.2 Chemical Computing Group Business Overview
- 6.11.3 Chemical Computing Group Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Chemical Computing Group Bio Simulation Product Portfolio
- 6.11.5 Chemical Computing Group Recent Developments
- 6.12 Certara LP
- 6.12.1 Certara LP Company Information
- 6.12.2 Certara LP Business Overview
- 6.12.3 Certara LP Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Certara LP Bio Simulation Product Portfolio
- 6.12.5 Certara LP Recent Developments
- 6.13 ANSYS Inc.
- 6.13.1 ANSYS Inc. Company Information
- 6.13.2 ANSYS Inc. Business Overview
- 6.13.3 ANSYS Inc. Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 ANSYS Inc. Bio Simulation Product Portfolio
- 6.13.5 ANSYS Inc. Recent Developments
- 6.14 Altair Engineering Inc.
- 6.14.1 Altair Engineering Inc. Company Information
- 6.14.2 Altair Engineering Inc. Business Overview
- 6.14.3 Altair Engineering Inc. Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Altair Engineering Inc. Bio Simulation Product Portfolio
- 6.14.5 Altair Engineering Inc. Recent Developments
- 6.15 Advanced Chemistry Development
- 6.15.1 Advanced Chemistry Development Company Information
- 6.15.2 Advanced Chemistry Development Business Overview
- 6.15.3 Advanced Chemistry Development Bio Simulation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Advanced Chemistry Development Bio Simulation Product Portfolio
- 6.15.5 Advanced Chemistry Development Recent Developments
7 North America
- 7.1 North America Bio Simulation Market Size (2021-2032)
- 7.2 North America Bio Simulation Market Size by Type
- 7.2.1 North America Bio Simulation Market Size by Type (2021-2026)
- 7.2.2 North America Bio Simulation Market Size by Type (2027-2032)
- 7.2.3 North America Bio Simulation Market Share by Type (2021-2032)
- 7.3 North America Bio Simulation Market Size by Application
- 7.3.1 North America Bio Simulation Market Size by Application (2021-2026)
- 7.3.2 North America Bio Simulation Market Size by Application (2027-2032)
- 7.3.3 North America Bio Simulation Market Share by Application (2021-2032)
- 7.4 North America Bio Simulation Market Size by Country
- 7.4.1 North America Bio Simulation Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Bio Simulation Market Size by Country (2021-2026)
- 7.4.3 North America Bio Simulation Market Size by Country (2027-2032)
- 7.4.4 North America Bio Simulation Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Bio Simulation Market Size (2021-2032)
- 8.2 Europe Bio Simulation Market Size by Type
- 8.2.1 Europe Bio Simulation Market Size by Type (2021-2026)
- 8.2.2 Europe Bio Simulation Market Size by Type (2027-2032)
- 8.2.3 Europe Bio Simulation Market Share by Type (2021-2032)
- 8.3 Europe Bio Simulation Market Size by Application
- 8.3.1 Europe Bio Simulation Market Size by Application (2021-2026)
- 8.3.2 Europe Bio Simulation Market Size by Application (2027-2032)
- 8.3.3 Europe Bio Simulation Market Share by Application (2021-2032)
- 8.4 Europe Bio Simulation Market Size by Country
- 8.4.1 Europe Bio Simulation Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Bio Simulation Market Size by Country (2021-2026)
- 8.4.3 Europe Bio Simulation Market Size by Country (2027-2032)
- 8.4.4 Europe Bio Simulation Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Bio Simulation Market Size (2021-2032)
- 9.2 China Bio Simulation Market Size by Type
- 9.2.1 China Bio Simulation Market Size by Type (2021-2026)
- 9.2.2 China Bio Simulation Market Size by Type (2027-2032)
- 9.2.3 China Bio Simulation Market Share by Type (2021-2032)
- 9.3 China Bio Simulation Market Size by Application
- 9.3.1 China Bio Simulation Market Size by Application (2021-2026)
- 9.3.2 China Bio Simulation Market Size by Application (2027-2032)
- 9.3.3 China Bio Simulation Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Bio Simulation Market Size (2021-2032)
- 10.2 Asia Bio Simulation Market Size by Type
- 10.2.1 Asia Bio Simulation Market Size by Type (2021-2026)
- 10.2.2 Asia Bio Simulation Market Size by Type (2027-2032)
- 10.2.3 Asia Bio Simulation Market Share by Type (2021-2032)
- 10.3 Asia Bio Simulation Market Size by Application
- 10.3.1 Asia Bio Simulation Market Size by Application (2021-2026)
- 10.3.2 Asia Bio Simulation Market Size by Application (2027-2032)
- 10.3.3 Asia Bio Simulation Market Share by Application (2021-2032)
- 10.4 Asia Bio Simulation Market Size by Country
- 10.4.1 Asia Bio Simulation Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Bio Simulation Market Size by Country (2021-2026)
- 10.4.3 Asia Bio Simulation Market Size by Country (2027-2032)
- 10.4.4 Asia Bio Simulation Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Bio Simulation Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Bio Simulation Market Size by Type
- 11.2.1 South America, Middle East & Africa Bio Simulation Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Bio Simulation Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Bio Simulation Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Bio Simulation Market Size by Application
- 11.3.1 South America, Middle East & Africa Bio Simulation Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Bio Simulation Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Bio Simulation Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Bio Simulation Market Size by Country
- 11.4.1 South America, Middle East & Africa Bio Simulation Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Bio Simulation Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Bio Simulation Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Bio Simulation Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst